CMA closes probe into three Concordia drugs

Janith Aranze

15 November 2018

CMA closes probe into three Concordia drugs

istock/zorazhuang

The UK’s competition enforcer has shuttered part of its antitrust probe of drugmaker Concordia after deciding it did not have the need or resources to continue investigating three of the company’s drugs.